gabexate has been researched along with Thrombopenia in 6 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Hepatic veno-occlusive disease (VOD) was suspected, and based on the laboratory data indicating enhanced coagulation, anticoagulant (gabexate mesylate; FOY), diuretic, and supportive therapy for hepatic failure was begun." | 7.68 | Veno-occlusive disease of the liver after combined adjuvant chemotherapy for a 1-year-old boy with rhabdomyosarcoma: potential usefulness of the gabexate mesylate (FOY). ( Adachi, N; Matsuda, I, 1992) |
| " Hepatic veno-occlusive disease (VOD) was suspected, and based on the laboratory data indicating enhanced coagulation, anticoagulant (gabexate mesylate; FOY), diuretic, and supportive therapy for hepatic failure was begun." | 3.68 | Veno-occlusive disease of the liver after combined adjuvant chemotherapy for a 1-year-old boy with rhabdomyosarcoma: potential usefulness of the gabexate mesylate (FOY). ( Adachi, N; Matsuda, I, 1992) |
| "These changes included acute disseminated intravascular coagulation, severe elevations of liver enzymes, severe renal dysfunction, and hemolytic anemia." | 1.27 | A case of postpartum hemolytic uremic syndrome with severe elevations of liver enzymes. ( Fujii, S; Kanzaki, H; Kariya, M; Matsuura, S; Mori, T; Sagawa, N, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakakura, M | 1 |
| Wada, H | 1 |
| Nomoto, Y | 1 |
| Hirose, Y | 1 |
| Tanaka, T | 1 |
| Kinoshita, H | 1 |
| Yamazaki, Y | 1 |
| Nonami, Y | 1 |
| Sasahashi, N | 1 |
| Satoh, K | 1 |
| Ogoshi, S | 1 |
| Tamiya, T | 1 |
| Adachi, N | 1 |
| Matsuda, I | 1 |
| Hashimoto, M | 1 |
| Wakabayashi, Y | 1 |
| Koike, M | 1 |
| Saito, K | 1 |
| Osawa, H | 1 |
| Ishiyama, T | 1 |
| Sugimoto, M | 1 |
| Hirose, S | 1 |
| Sagawa, N | 1 |
| Kariya, M | 1 |
| Kanzaki, H | 1 |
| Fujii, S | 1 |
| Matsuura, S | 1 |
| Mori, T | 1 |
1 review available for gabexate and Thrombopenia
| Article | Year |
|---|---|
[Prevention of hemorrhage occurring in patients with leukemia].
Topics: Anticoagulants; Disseminated Intravascular Coagulation; Gabexate; Heparin; Humans; Leukemia; Platele | 2003 |
5 other studies available for gabexate and Thrombopenia
| Article | Year |
|---|---|
Heparin-induced thrombocytopenia, anomalous laboratory findings lead to the correct diagnosis.
Topics: Cerebral Infarction; Clinical Laboratory Techniques; Diagnosis, Differential; Follow-Up Studies; Gab | 2007 |
[A case report: mitral valve replacement for the patient with essential thrombocythemia].
Topics: Gabexate; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Stenosis; Pe | 1993 |
Veno-occlusive disease of the liver after combined adjuvant chemotherapy for a 1-year-old boy with rhabdomyosarcoma: potential usefulness of the gabexate mesylate (FOY).
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Chemotherapy, Adjuvant; C | 1992 |
[Gabexate mesilate induced remarkable transient reversal of thrombocytopenia in a ITP patient].
Topics: Female; Gabexate; Guanidines; Humans; Middle Aged; Platelet Count; Purpura, Thrombocytopenic; Remiss | 1991 |
A case of postpartum hemolytic uremic syndrome with severe elevations of liver enzymes.
Topics: Adult; Alkaline Phosphatase; Disseminated Intravascular Coagulation; Female; Furosemide; Gabexate; G | 1985 |